207 related articles for article (PubMed ID: 14970324)
1. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.
Wang TL; Diaz LA; Romans K; Bardelli A; Saha S; Galizia G; Choti M; Donehower R; Parmigiani G; Shih IeM; Iacobuzio-Donahue C; Kinzler KW; Vogelstein B; Lengauer C; Velculescu VE
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3089-94. PubMed ID: 14970324
[TBL] [Abstract][Full Text] [Related]
2. Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy.
Watson RG; Muhale F; Thorne LB; Yu J; O'Neil BH; Hoskins JM; Meyers MO; Deal AM; Ibrahim JG; Hudson ML; Walko CM; McLeod HL; Auman JT
Eur J Cancer; 2010 Dec; 46(18):3358-64. PubMed ID: 20727737
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients.
Abdallah EA; Fanelli MF; Buim ME; Machado Netto MC; Gasparini Junior JL; Souza E Silva V; Dettino AL; Mingues NB; Romero JV; Ocea LM; Rocha BM; Alves VS; Araújo DV; Chinen LT
Int J Cancer; 2015 Sep; 137(6):1397-405. PubMed ID: 25721610
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
6. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Li T; Gao F; Zhang XP
Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
[TBL] [Abstract][Full Text] [Related]
7. Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.
Chazal M; Cheradame S; Formento JL; Francoual M; Formento P; Etienne MC; François E; Richelme H; Mousseau M; Letoublon C; Pezet D; Cure H; Seitz JF; Milano G
Clin Cancer Res; 1997 Apr; 3(4):553-7. PubMed ID: 9815719
[TBL] [Abstract][Full Text] [Related]
8. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment.
Torén W; Ansari D; Andersson B; Spelt L; Andersson R
Future Oncol; 2018 Feb; 14(4):343-351. PubMed ID: 29318904
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer.
Sun Z; Zhou N; Han Q; Zhao L; Bai C; Chen Y; Zhou J; Zhao RC
Clin Transl Oncol; 2015 Nov; 17(11):876-83. PubMed ID: 26055341
[TBL] [Abstract][Full Text] [Related]
11. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
12. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase.
Milczarek M; Rossowska J; Klopotowska D; Stachowicz M; Kutner A; Wietrzyk J
J Steroid Biochem Mol Biol; 2019 Jun; 190():139-151. PubMed ID: 30923017
[TBL] [Abstract][Full Text] [Related]
13. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression.
Varghese V; Magnani L; Harada-Shoji N; Mauri F; Szydlo RM; Yao S; Lam EW; Kenny LM
Sci Rep; 2019 Feb; 9(1):1505. PubMed ID: 30728402
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
Sharma R; Hoskins JM; Rivory LP; Zucknick M; London R; Liddle C; Clarke SJ
Clin Cancer Res; 2008 Feb; 14(3):817-25. PubMed ID: 18245544
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M
Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371
[TBL] [Abstract][Full Text] [Related]
17. Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen.
Ichikawa W; Takahashi T; Suto K; Sasaki Y; Hirayama R
Clin Cancer Res; 2006 Jul; 12(13):3928-34. PubMed ID: 16818689
[TBL] [Abstract][Full Text] [Related]
18. Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer.
Cho YB; Chung HJ; Lee WY; Choi SH; Kim HC; Yun SH; Chun HK
Anticancer Res; 2011 Nov; 31(11):3843-9. PubMed ID: 22110208
[TBL] [Abstract][Full Text] [Related]
19. Sodium Butyrate Inhibits the Expression of Thymidylate Synthase and Induces Cell Death in Colorectal Cancer Cells.
Kim N; Yang C
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338851
[TBL] [Abstract][Full Text] [Related]
20. Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.
Koumarianou A; Tzeveleki I; Mekras D; Eleftheraki AG; Bobos M; Wirtz R; Fountzilas E; Valavanis C; Xanthakis I; Kalogeras KT; Basdanis G; Pentheroudakis G; Kotoula V; Fountzilas G
Anticancer Res; 2014 Sep; 34(9):4949-62. PubMed ID: 25202077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
